ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,242.00
      1.55%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.02%
      Bitcoin
      63,739.03
      -1.16%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. T2 Biosystems Inc (TTOO)

      7. T2 Biosystems Inc (TTOO) News

      TTOO

      T2 Biosystems (TTOO)

      T2 Biosystems Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TTOO
      DateTimeSourceHeadlineSymbolCompany
      04/24/20249:00AMGlobeNewswire Inc.T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024NASDAQ:TTOOT2 Biosystems Inc
      04/11/20244:05PMGlobeNewswire Inc.T2 Biosystems Shareholders Vote for CRG Debt Conversion into EquityNASDAQ:TTOOT2 Biosystems Inc
      03/28/20249:00AMGlobeNewswire Inc.T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.NASDAQ:TTOOT2 Biosystems Inc
      03/20/20247:30AMGlobeNewswire Inc.T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
      03/19/20249:00AMGlobeNewswire Inc.T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business UpdatesNASDAQ:TTOOT2 Biosystems Inc
      03/18/20249:00AMGlobeNewswire Inc.T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance PanelNASDAQ:TTOOT2 Biosystems Inc
      03/12/20249:00AMGlobeNewswire Inc.T2 Biosystems Receives Extension to Comply with Nasdaq Listing RequirementNASDAQ:TTOOT2 Biosystems Inc
      03/04/20244:34PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TTOOT2 Biosystems Inc
      02/27/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/27/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/27/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/20/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/20/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/20/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/20/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/16/20245:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      02/16/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
      02/15/20244:49PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TTOOT2 Biosystems Inc
      02/15/20244:47PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
      02/15/20244:06PMGlobeNewswire Inc.T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TTOOT2 Biosystems Inc
      02/15/20244:04PMGlobeNewswire Inc.T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into EquityNASDAQ:TTOOT2 Biosystems Inc
      02/15/20244:02PMGlobeNewswire Inc.T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and AsiaNASDAQ:TTOOT2 Biosystems Inc
      02/13/20248:15PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TTOOT2 Biosystems Inc
      02/12/20249:00AMGlobeNewswire Inc.T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria PanelNASDAQ:TTOOT2 Biosystems Inc
      02/07/20244:05PMGlobeNewswire Inc.T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024NASDAQ:TTOOT2 Biosystems Inc
      01/18/20249:00AMGlobeNewswire Inc.T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia PatientsNASDAQ:TTOOT2 Biosystems Inc
      01/05/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TTOOT2 Biosystems Inc
      01/03/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
      01/03/20249:00AMGlobeNewswire Inc.T2 Biosystems Announces FDA 510(k) Submission to Expand Use of the FDA-Cleared T2Candida Panel to Include Pediatric TestingNASDAQ:TTOOT2 Biosystems Inc
      11/28/20234:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TTOOT2 Biosystems Inc
       Showing the most relevant articles for your search:NASDAQ:TTOO